TR

Transcend Therapeutics

4 known investors

transcendtherapeutics.com ↗

Transcend Therapeutics develops rapid-acting pharmaceutical treatments for neuropsychiatric diseases, including PTSD and depression, targeting patients unresponsive to current psychiatric medications. The company is a clinical-stage biotech firm focused on neuroscience-based drug development.

Investors · 4

AL

AlleyCorpNew York · $1M – $5M

AL

Alpha Wave GlobalMiami

EM

Emerald Development ManagersNew York

AL

Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred